Literature DB >> 18333023

Successful repair of Bismuth type 2 bile duct stricture by T-tube stented omentoplasty: 19 years follow-up.

K Meissner1.   

Abstract

BACKGROUND: The 'gold standard' of surgical repair of extrahepatic bile duct strictures is hepaticojejunostomy (HJ). This is a proven procedure with the drawback of a nonanatomic bile duct drainage by passing the ampullary sphincter system. On theoretical grounds an anatomical reconstruction would be desirable. CASE OUTLINE: This case demonstrates the possibility of repairing a Bismuth type 2 stricture with a longitudinal incision and a T-tube stented omentoplasty. After a follow-up of 19 years, the reconstruction rendered an anatomically and physiologically normal repair. DISCUSSION: Stented omentoplasty may be an alternative to HJ in Bismuth type 1 and 2 lesions.The success of this unorthodox repair technique does not warrant a general recommendation at this stage, however. Pertinent analogous literature reports are scarce, and the evidence base is very limited.The case report is rather intended as an incentive for further research outlining the possibilities and limitations of this technique.

Year:  2001        PMID: 18333023      PMCID: PMC2020620          DOI: 10.1080/136518201753242299

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  1 in total

1.  [Approach to and use of the left hepatic duct in reparation of the common bile duct].

Authors:  J HEPP; C COUINAUD
Journal:  Presse Med       Date:  1956-05-23       Impact factor: 1.228

  1 in total
  2 in total

1.  The application of vascularized stomach flap to repair postoperative biliary stricture.

Authors:  Jianping Zeng; Jing Wang; Jiahong Dong; Xiaoqiang Huang; Hongtian Xia; Xin Xiang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

2.  Pedicled omental patch as a bridging procedure for iatrogenic bile duct injury.

Authors:  Jun Jie Ng; Alfred Wei Chieh Kow
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.